Purinergic signaling in Parkinson’s disease (2023)
- Authors:
- USP affiliated authors: ULRICH, ALEXANDER HENNING - IQ ; BRITTO, LUIZ ROBERTO GIORGETTI DE - ICB ; SILVA, JEAN BEZERRA - IQ ; FERREIRA, ANA FLAVIA FERNANDES - ICB ; GLASER, TALITA - IQ
- Unidades: IQ; ICB
- Assunto: DOENÇA DE PARKINSON
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration
- Volume/Número/Paginação/Ano: 376 p
-
ABNT
SILVA, Jean Bezerra et al. Purinergic signaling in Parkinson’s disease. Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Tradução . Cham: Springer, 2023. . . Acesso em: 30 abr. 2024. -
APA
Silva, J. B., Ferreira, A. F. F., Glaser, T., Ulrich, H., & Britto, L. R. G. de. (2023). Purinergic signaling in Parkinson’s disease. In Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Cham: Springer. -
NLM
Silva JB, Ferreira AFF, Glaser T, Ulrich H, Britto LRG de. Purinergic signaling in Parkinson’s disease. In: Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Cham: Springer; 2023. [citado 2024 abr. 30 ] -
Vancouver
Silva JB, Ferreira AFF, Glaser T, Ulrich H, Britto LRG de. Purinergic signaling in Parkinson’s disease. In: Purinergic signaling in neurodevelopment, neuroinflammation and neurodegeneration. Cham: Springer; 2023. [citado 2024 abr. 30 ] - The transient receptor potential melastatin 2: a new therapeutical target for Parkinson’s disease?
- Inhibition of TRPM2 by AG490 is neuroprotective in a Parkinson’s Disease animal model
- Purinergic receptors in neurogenic processes
- Purinergic signaling: an overview
- Purinergic Signaling in Neurodevelopment, Neuroinflammation and Neurodegeneration
- Huntingtin protein maintains balanced energetics in mouse cardiomyocytes
- Purinergic signaling in brain physiology
- Therapeutic effects of cannabinoids and their applications in COVID-19 treatment
- P2Y2 receptor activation promotes esophageal cancer cells proliferation via ERK1/2 pathway
- Adenosinergic-dopaminergic signaling in mood disorders: a mini-review
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
